Evidence map›Paper›PMID 41085690›Full record

ArticleInternational journal of surgery (London, England)2026

4D CT-guided parathyroidectomy: improving operative efficiency in end-stage renal disease patients with medically refractory secondary hyperparathyroidism.

Wen-Hui Chan, Yung-Yuan Chan, Yi-Fu Chen, Hao-Wei Kou, Ming-Yang Chen, Chun-Yi Tsai, Shang-Yu Wang, Ya-Chung Tian, Chun-Nan Yeh

Abstract readComparative Study
In one paragraph

Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wen-Hui ChanDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, and Chang Gung University College of Medicine, Taoyuan, Taiwan.
Yung-Yuan ChanDepartment of Surgery, Division of General Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.
Yi-Fu ChenDepartment of Surgery, Division of General Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.
Hao-Wei KouDepartment of Surgery, Division of General Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.
Ming-Yang ChenDepartment of Surgery, Division of General Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.
Chun-Yi TsaiDepartment of Surgery, Division of General Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.
Shang-Yu WangDepartment of Surgery, Division of General Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.
Ya-Chung TianKidney Research Center, Chang Gung Memorial Hospital at Linkou, Linkou, Taiwan.
Chun-Nan YehDepartment of Surgery, Division of General Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.ORCID 0000-0003-1455-092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParathyroidectomy for medically refractory secondary hyperparathyroidism in patients with end-stage renal disease (ESRD) traditionally relies on experience-dependent surgical exploration due to limited preoperative localization capabilities. This study evaluates whether four-dimensional computed tomography (4D CT) provides significant improvements in surgical efficiency with measurable operative benefits.

methodsThis retrospective comparative study analyzed 103 patients with ESRD undergoing total or subtotal parathyroidectomy between January 2023 and December 2024. Patients were stratified into two groups: 4D CT-guided focused parathyroidectomy ( n = 45) versus conventional imaging-guided surgery using ultrasound ± SPECT(Single Photon Emission Computed Tomography)/CT ( n = 58). Primary endpoints included operative time and intraoperative frozen section requirements. Secondary endpoints assessed diagnostic accuracy and positive predictive value (PPV) of imaging modalities, with postoperative outcomes evaluated to ensure therapeutic equivalence.

resultsThe 4D CT group demonstrated significantly shorter operative times compared to conventional imaging (162.51 vs. 188.78 min, P = 0.014), representing a 13.9% reduction in surgical duration. Multiple frozen sections were required in 8.9% of 4D CT patients versus 31.0% of conventional patients ( P = 0.013), demonstrating a 3.5-fold reduction in intraoperative histological confirmation needs. 4D CT showed superior diagnostic accuracy (75% vs. 33.33%) and PPV (93.75% vs. 85.0%) compared to conventional imaging. Multivariate analysis identified 4D CT as the only independent predictor of reduced frozen section requirements (odds ratio: 0.21, 95% confidence interval: [0.06-0.68]; P = 0.009). Postoperative outcomes including biochemical control and complication rates were equivalent between groups, demonstrating that enhanced surgical efficiency did not compromise therapeutic effectiveness.

conclusions4D CT significantly enhances surgical efficiency in ESRD patients with medically refractory secondary hyperparathyroidism through improved preoperative localization. These efficiency gains are achieved while maintaining therapeutic effectiveness.

Indexed as

Four-Dimensional Computed TomographyHyperparathyroidism, SecondaryKidney Failure, ChronicParathyroidectomySurgery, Computer-AssistedAdultAgedFemaleHumansMaleMiddle AgedOperative TimeRetrospective StudiesTreatment Outcome4-dimentional computed-tomographyend-stage renal diseasefocused surgeryparathyroidectomysecondary hyperparathyroidism

Identifiers

PMID41085690
PMCPMC12825668

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.